2017 International Congress

Tuesday, June 6, 2017

1:45pm-3:15pm

Beneficial and Protective Effects of Withania Someniferais On Mice Brain: A Therapeutic Potential Drug for Parkinson’s Disease

S. Rajput, S. Sinha (New Delhi, India)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C

1:45pm-3:15pm

Botulinum Neurotoxin (BoNT) for treatment of functional (psychogenic) jerky movement disorders: a randomized placebo-controlled clinical trial

Y. Dreissen, J. Dijk, J. Gelauff, E. Zoons, M. Contarino, R. Zutt, B. Post, D. van Poppelen, A. Munts, J. Speelman, R. de Haan, J. Koelman, M. Tijssen (Amsterdam, Netherlands)

Therapy in Movement Disorders  ·  Exhibit Hall C

1:45pm-3:15pm

Brain insulin resistance in Parkinson’s disease

F. Bassil, M.-H. Canron, N. Dutheil, A. Vital, E. Bezard, P.-O. Fernagut, W. Meissner (Bordeaux, France)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C

1:45pm-3:15pm

C19orf12 p.Thr11Met mutation is frequent among adult Turkish patients with MPAN

M. Quadri, S. Olgiati, O. Doğu, Z. Tufekcioglu, Y. Diler, E. Saka, M. Gultekin, H. Kaleagasi, D. Kuipers, J. Graafland, G. Breedveld, R. Sürmeli, G. Sünter, T. Doğan, A.D. Yalçın, B. Bilgiç, B. Elibol, M. Emre, H. Hanagasi, V. Bonifati (Rotterdam, Netherlands)

Genetics (Non-PD)  ·  Exhibit Hall C

1:45pm-3:15pm

Can three-dimensional visual cues delivered via smart glasses reduce freezing of gait in patients with Parkinson’s Disease?

S. Janssen, J. Nonnekes, B. Bolte, M. Bittner, T. Heida, Y. Zhao, R. van Wezel (Enschede, Netherlands)

Technology  ·  Exhibit Hall C

1:45pm-3:15pm

Cannabis and Parkinson’s Disease Tremor

L. Mischley, R. Bennett, M. Sexton, G. Ricciardi, J. McNames (Kenmore, WA, USA)

Tremor  ·  Exhibit Hall C

1:45pm-3:15pm

Case study: Real-time MRI articulatory comparison of a congenital aglossic and normal speaker

B. McMicken (Irvine,  , CA, USA)

Pathophysiology (Other Movement Disorders)  ·  Exhibit Hall C

1:45pm-3:15pm

Catecholamines’ concentration ratio in plasma of early diagnosed treatment-naive patients with Parkinson disease

Z. Zalyalova, D. Khasanova (Kazan, Russian Federation)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C

1:45pm-3:15pm

CB2R agonist AM1241 reverses the development of MPTP-induced PD and activates the regeneration of DA neurons

R. Zhu (Shanghai, China)

Therapy in Movement Disorders  ·  Exhibit Hall C

1:45pm-3:15pm

Cerebello-cortical loops differ between Essential-, Parkinsonian- and voluntary tremor

J. Raethjen, M. Muthuraman, S. Groppa, G. Deuschl (Kiel, Germany)

Tremor  ·  Exhibit Hall C